Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians

PURPOSE: Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemotherapy in ER-positive, HER2-negative, early-stage breast cancer. As health literacy and numeracy skills in the general population are poor, healthcare professionals (HCPs) require...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallowfield, L., Solis-Trapala, I., Starkings, R., Catt, S., May, S., Jenkins, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745030/
https://www.ncbi.nlm.nih.gov/pubmed/31201584
http://dx.doi.org/10.1007/s10549-019-05316-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745030/
https://www.ncbi.nlm.nih.gov/pubmed/31201584
http://dx.doi.org/10.1007/s10549-019-05316-7

Ejemplares similares